*<p>Values shown are means ±SD, unless otherwise indicated.</p>†<p>P values were calculated with the t test for quantitative variables or Chi-square test for categorical ones, except for HOMA-IR, HOMA-B, fasting insulin, fasting leptin and fasting adiponectin, where non-parametric Mann-Whitney U test was applied.</p>‡<p>HOMA-IR was calculated as [Insulin mUI/l x Glycemia: (mmol/l)/22.5].</p>§<p>HOMA-B was calculated as (20 × FPI)/(FPG − 3.5), where FPI is the fasting plasma insulin concentration (mU/l) and FPG is fasting plasma glucose (mmol/l).</p
<p> = 715.<sup></sup> Cohort size: n</p><p>±SD or percentages. ND = not determined. A1C: glycated h...
<p>Mean and ± standard deviation are shown for continuous variables. Age, triglycerides, HbA<sub>1c<...
The reported glucose and immunoreactive insulin (IRI) responses to oral and intravenous glucose in s...
<p>* Values shown are means ±SD, unless otherwise indicated.</p>†<p>P values were calculated with th...
<p>Abbreviations: BMI, body mass index; TC, total cholesterol; TG, triglycerides; FPG, fasting plasm...
<p>Data are mean ± SD values.</p><p>Abbreviations: BMI, body mass index; HDL-C, high density lipopro...
<p>BMI: body mass index; HbA1c: glycated hemoglobin</p><p>Main clinical characteristics and metaboli...
<p>** p<0.01 obese Vs control; p<0.01 NIDM Vs Control, ¥p<0.01 obese Vs NIDM; NS: Not Significant. (...
<p>Data are shown as mean ± SEM</p><p>Anthropometry and metabolic characteristics of the Type 2 diab...
<p>Student’s t-test. female vs male *P<0.05, #P<0.01.</p><p>BMI, body mass index; HbA1c, glycosylate...
<p>Data are shown as the mean±SD or n; FH: fasting hyperglycemia; LLI: long-lived individuals; MI_S:...
<p>(A): Levels of HOMA-IR among non-type 2 diabetes group; (B): Levels of HOMA-IR among type 2 diabe...
†<p>Log transformed before analysis.</p><p>subAS, subclinical atherosclerosis; M, male; F, female; B...
<p>Data are means ±SD unless indicated otherwise. TG, INS, HOMA-IR and HOMA-β are shown as median an...
We evaluated changes in glucose tolerance of 17 progressors and 62 non-progressors for 9 years to im...
<p> = 715.<sup></sup> Cohort size: n</p><p>±SD or percentages. ND = not determined. A1C: glycated h...
<p>Mean and ± standard deviation are shown for continuous variables. Age, triglycerides, HbA<sub>1c<...
The reported glucose and immunoreactive insulin (IRI) responses to oral and intravenous glucose in s...
<p>* Values shown are means ±SD, unless otherwise indicated.</p>†<p>P values were calculated with th...
<p>Abbreviations: BMI, body mass index; TC, total cholesterol; TG, triglycerides; FPG, fasting plasm...
<p>Data are mean ± SD values.</p><p>Abbreviations: BMI, body mass index; HDL-C, high density lipopro...
<p>BMI: body mass index; HbA1c: glycated hemoglobin</p><p>Main clinical characteristics and metaboli...
<p>** p<0.01 obese Vs control; p<0.01 NIDM Vs Control, ¥p<0.01 obese Vs NIDM; NS: Not Significant. (...
<p>Data are shown as mean ± SEM</p><p>Anthropometry and metabolic characteristics of the Type 2 diab...
<p>Student’s t-test. female vs male *P<0.05, #P<0.01.</p><p>BMI, body mass index; HbA1c, glycosylate...
<p>Data are shown as the mean±SD or n; FH: fasting hyperglycemia; LLI: long-lived individuals; MI_S:...
<p>(A): Levels of HOMA-IR among non-type 2 diabetes group; (B): Levels of HOMA-IR among type 2 diabe...
†<p>Log transformed before analysis.</p><p>subAS, subclinical atherosclerosis; M, male; F, female; B...
<p>Data are means ±SD unless indicated otherwise. TG, INS, HOMA-IR and HOMA-β are shown as median an...
We evaluated changes in glucose tolerance of 17 progressors and 62 non-progressors for 9 years to im...
<p> = 715.<sup></sup> Cohort size: n</p><p>±SD or percentages. ND = not determined. A1C: glycated h...
<p>Mean and ± standard deviation are shown for continuous variables. Age, triglycerides, HbA<sub>1c<...
The reported glucose and immunoreactive insulin (IRI) responses to oral and intravenous glucose in s...